Get the Stockscreener App
57.08
6.10%
3.28
After Hours:
57.04
-0.04
-0.07%
Belite Bio Inc Adr Stock (BLTE) Latest News
Belite Bio (NASDAQ:BLTE) Trading Down 4.7%Should You Sell? - MarketBeat
Advisors Preferred LLC Purchases New Shares in Belite Bio, Inc (NASDAQ:BLTE) - Armenian Reporter
Belite Bio Announces $15 Million Direct Offering to Enhance Financial Position - TipRanks
BLTEBelite Bio, Inc American Depositary Shares Latest Stock News & Market Updates - StockTitan
Sangoma Announces Second Quarter Fiscal 2025 Results - The Globe and Mail
Why Oklo Stock Jumped 96% in January - The Globe and Mail
Belite Bio Raises Fresh Capital: $30M Total Potential as Clinical Programs Advance - StockTitan
Belite Bio Announces Registered Direct Offering of $15 Million - GlobeNewswire Inc.
Flow Beverage Corp. Adds José Bautista as Strategic Advisor and Closes Second Tranche of Private Placement of Convertible Debenture Units - The Globe and Mail
Why Dominion Energy Stock Was Falling Today - The Globe and Mail
Leerink Partnrs Increases Earnings Estimates for Belite Bio - MarketBeat
Belite Bio, Inc (NASDAQ:BLTE) Stake Increased by JPMorgan Chase & Co. - MarketBeat
Where Will Nvidia Stock Be in 3 Years? - The Globe and Mail
Apple Stock Is Off Its Recent Highs, But Is It Poised to Rise Again? - The Globe and Mail
Short Interest in Belite Bio, Inc (NASDAQ:BLTE) Decreases By 60.3% - MarketBeat
Bitcoin: Buy the Dip? - The Globe and Mail
JPMorgan Chase & Co. Grows Stock Holdings in Belite Bio, Inc (NASDAQ:BLTE) - Defense World
Is Coffee Moving to Even Higher Highs? - The Globe and Mail
Charter (CHTR) Reports Q4: Everything You Need To Know Ahead Of Earnings - The Globe and Mail
Are These Renewable Energy Stocks in Trouble, or Are They Ultra-Cheap Buys? - The Globe and Mail
The Ultimate Growth Stock to Buy With $1,000 Right Now - The Globe and Mail
Rigetti CEO Responds to Jensen Huang and Mark Zuckerberg on the Future of Quantum Computing - The Globe and Mail
Avoid the Trap: 3 High-yield Dividend Stocks With Safe Payouts - The Globe and Mail
2 Artificial Intelligence Stocks You Can Buy and Hold for the Next Decade - The Globe and Mail
4 Soaring Stocks I'd Buy Now With No Hesitation - The Globe and Mail
Analysts Predict 1,250% Upside for This ‘Strong Buy’ Quantum Computing Stock in 2025... But Investors Should Stay Away - The Globe and Mail
XFRA : ICFFRENDE DER HANDELSUNTERBRECHUNG IN DIVERSEN AKTIENTEIL 2 () - Aktiencheck
Belite Bio (NASDAQ:BLTE) Shares Gap Up After Analyst Upgrade - Defense World
Belite Bio (NASDAQ:BLTE) Shares Gap Up Following Analyst Upgrade - MarketBeat
Benchmark Issues Positive Forecast for Belite Bio (NASDAQ:BLTE) Stock Price - Defense World
Benchmark Boosts Belite Bio (NASDAQ:BLTE) Price Target to $79.00 - MarketBeat
Benchmark sees growth for Belite Bio shares, highlights Tinlarebant's promise in rare diseases - Investing.com
ATS to Participate in the Citi Global Industrial Tech and Mobility Conference - The Globe and Mail
Belite Bio (NASDAQ:BLTE) Trading 5.4% HigherHere's Why - MarketBeat
Belite Bio (NASDAQ:BLTE) Sees Unusually-High Trading VolumeWhat's Next? - MarketBeat
Belite Bio, Inc (NASDAQ:BLTE) Short Interest Down 60.3% in December - MarketBeat
GAMMA Investing LLC Buys 419 Shares of Belite Bio, Inc (NASDAQ:BLTE) - Defense World
If You'd Invested $1,000 in Tesla Stock 10 Years Ago, Here's How Much You'd Have Today - The Globe and Mail
Belite Bio (NASDAQ:BLTE) Shares Down 4.2%Should You Sell? - MarketBeat
Belite Bio, Inc (NASDAQ:BLTE) Shares Purchased by State Street Corp - Defense World
What is HC Wainwright’s Estimate for MetaVia Q4 Earnings? - Defense World
Short Interest in Belite Bio, Inc (NASDAQ:BLTE) Declines By 12.9% - MarketBeat
Stargardt Disease Therapeutics Market Size in the 7MM was ~USD 27 million in 2023, which is expected to increase by 2034, estimated DelveInsight - The Globe and Mail
Stargardt Disease Therapeutics Market Size in the 7MM was ~USD 27 - openPR
Wedbush Just Pushed Tesla Stock to New All-Time Highs. Is It Too Late to Buy? - The Globe and Mail
AI’s Next Big Winners: 3 Small-Cap Stocks to Watch in 2025 - The Globe and Mail
Where Will Costco Stock Be in 3 Years? - The Globe and Mail
Belite Bio (NASDAQ:BLTE) Shares Gap UpStill a Buy? - MarketBeat
Facebook, UnitedHealth among Friday's market cap stock movers By Investing.com - Investing.com Nigeria
Facebook, UnitedHealth among Friday's market cap stock movers - Investing.com India
Belite Bio (NASDAQ:BLTE) Trading Down 3.4%What's Next? - MarketBeat
Do you want more choice and competition for your Internet service? TELUS is urging Canadians to sign its #YourInternetYourChoice petition - The Globe and Mail
2.27%
5.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):